ArticleJournal for immunotherapy of cancer2022

Preclinical characterization of the novel anti-SIRPα antibody BR105 that targets the myeloid immune checkpoint.

Zhen-Hua Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.